GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Evoke PLC (LSE:EVOK) » Definitions » 3-Year EPS without NRI Growth Rate

Evoke (LSE:EVOK) 3-Year EPS without NRI Growth Rate : -18.40% (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Evoke 3-Year EPS without NRI Growth Rate?

Evoke's EPS without NRI for the six months ended in Dec. 2023 was £0.08.

During the past 12 months, Evoke's average EPS without NRI Growth Rate was -27.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was -18.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was -1.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 3.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Evoke was 66.40% per year. The lowest was -28.10% per year. And the median was 11.70% per year.


Competitive Comparison of Evoke's 3-Year EPS without NRI Growth Rate

For the Gambling subindustry, Evoke's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evoke's 3-Year EPS without NRI Growth Rate Distribution in the Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, Evoke's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Evoke's 3-Year EPS without NRI Growth Rate falls into.



Evoke 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Evoke  (LSE:EVOK) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Evoke 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Evoke's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Evoke (LSE:EVOK) Business Description

Industry
Traded in Other Exchanges
Address
Europort Road, Suite 601/701, Europort, GIB
888 Holdings PLC is an online betting and gaming company. The company operates in three business segments; The Retail segment comprises all activity undertaken in LBOs including gaming machines, The UK Online segment comprises all online activity, including sports betting, casino, poker, and other gaming products along with telephone betting services that are incurred within the UK and Ireland, and The International segment comprises all online activity, including sports betting, casino, poker, and other gaming products along with telephone betting services that are incurred within all territories excluding the UK. It derives a majority of its revenue from the United Kingdom.

Evoke (LSE:EVOK) Headlines

From GuruFocus

Evoke Announces Teva Ends Pursuit of Paragraph IV ANDA Against Gimoti

By Stock market mentor Stock market mentor 01-30-2023

Evoke Pharma to Report Third Quarter Results on November 9, 2022

By Value_Insider Value_Insider 11-02-2022